Related Experiment Video
Updated: Aug 29, 2025

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells
Published on: June 5, 2020
Effects of Hepatitis B Virus Infection on Patients with COVID-19: A Meta-Analysis
Yang Yu1, Xingzhao Li2, Taihu Wan3
1Department of Hepatobiliary and Pancreatic Surgery, China-Japan Union Hospital of Jilin University, Changchun, 130033, Jilin Province, China.
Insights
Hepatitis B virus (HBV) infection significantly increases mortality and severity in COVID-19 patients. Liver function indices require close monitoring during treatment for these patients.
Area of Science:
- Hepatology
- Infectious Diseases
- Critical Care Medicine
Background:
- The COVID-19 pandemic presents unique challenges for patients with pre-existing Hepatitis B virus (HBV) infection.
- Understanding the impact of HBV on COVID-19 outcomes is crucial for patient management.
Approach:
- A comprehensive meta-analysis was conducted using data from PubMed, Embase, and Web of Science.
- The study adhered to the PRISMA guideline, employing a random-effects model for analysis.
- 37,696 patients were analyzed, comparing 2,591 COVID-19 patients with HBV to 35,105 COVID-19 patients without HBV.
Key Points:
- COVID-19 patients with HBV exhibited significantly higher in-hospital mortality (OR=2.04) and a greater likelihood of developing severe disease (OR=1.90).
- HBV infection was associated with elevated liver function markers, including ALT, AST, total bilirubin, direct bilirubin, and LDH.
- Elevated liver enzymes (ALT, AST, bilirubin, LDH) were significantly higher in COVID-19 patients with HBV.
Conclusions:
- COVID-19 patients co-infected with HBV require heightened clinical attention.
- Close monitoring of liver function tests is essential for managing COVID-19 patients with HBV.
Background:
The COVID-19 pandemic has brought new problems to patients infected with hepatitis B virus (HBV).
Aim:
We aim to know the effects of HBV infection on patients with COVID-19.
Methods:
We searched PubMed, Embase, and Web of Science for data and utilized Stata 14.0 software for this meta-analysis with a random-effects model. This paper was conducted in alignment with the preferred reporting items for systematic review and meta-analysis (PRISMA) guideline.
Results:
In total, 37,696 patients were divided into two groups: 2591 COVID-19 patients infected with HBV in the experimental group and 35,105 COVID-19 patients not infected with HBV in the control group. Our study showed that the in-hospital mortality of the experimental group was significant higher than that of the control group (OR = 2.04, 95% CI 1.49-2.79). We also found that COVID-19 patients infected with HBV were more likely to develop severe disease (OR = 1.90, 95% CI 1.32-2.73) than COVID-19 patients not infected with HBV. Upon measuring alanine aminotransferase (SMD = 0.62, 95% CI 0.25-0.98), aspartate aminotransferase (SMD = 0.60, 95% CI 0.30-0.91), total bilirubin (SMD = 0.45, 95% CI 0.23-0.67), direct bilirubin (SMD = 0.36, 95% CI 0.24-0.47), lactate dehydrogenase (SMD = 0.32, 95% CI 0.18-0.47), we found that HBV infection led to significantly higher laboratory results in COVID-19 patients.
Conclusion:
COVID-19 patients infected with HBV should receive more attention, and special attention should be given to various liver function indices during treatment.
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Myocarditis III: Medical Management
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Viruses with RNA Genomes

